These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 8230131

  • 1. Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo.
    Sonesson C, Boije M, Svensson K, Ekman A, Carlsson A, Romero AG, Martin IJ, Duncan JN, King LJ, Wikström H.
    J Med Chem; 1993 Oct 29; 36(22):3409-16. PubMed ID: 8230131
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Oral cavity absorption of (R)-8-hydroxy-2-(di-n-propylamino)tetralin and (S)-8-acetyl-2-(di-n-propylamino)tetralin in the rat.
    Yu H, Liu Y, Hacksell U, Lewander T.
    J Pharm Pharmacol; 1996 Jan 29; 48(1):41-5. PubMed ID: 8722493
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists.
    Arvidsson LE, Hacksell U, Johansson AM, Nilsson JL, Lindberg P, Sanchez D, Wikström H, Svensson K, Hjorth S, Carlsson A.
    J Med Chem; 1984 Jan 29; 27(1):45-51. PubMed ID: 6418888
    [Abstract] [Full Text] [Related]

  • 9. Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Mellin C, Björk L, Karlén A, Johansson AM, Sundell S, Kenne L, Nelson DL, Andén NE, Hacksell U.
    J Med Chem; 1988 Jun 29; 31(6):1130-40. PubMed ID: 2967376
    [Abstract] [Full Text] [Related]

  • 10. (S)- and (R)-8-(di-n-propylamino)-6,7,8,9-tetrahydro-3H-benz[e]indole-1- carbaldehyde: a new class of orally active 5-HT1A-receptor agonists.
    Stjernlöf P, Gullme M, Elebring T, Andersson B, Wikström H, Lagerquist S, Svensson K, Ekman A, Carlsson A, Sundell S.
    J Med Chem; 1993 Jul 23; 36(15):2059-65. PubMed ID: 8340910
    [Abstract] [Full Text] [Related]

  • 11. (R)- and (S)-8-acetyl-2-(dipropylamino)tetralin (LY-41): two novel 5-HT1A receptor agonists.
    Yu H, Liu Y, Hacksell U, Lewander T.
    Eur J Pharmacol; 1993 Jan 26; 231(1):69-76. PubMed ID: 8444282
    [Abstract] [Full Text] [Related]

  • 12. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
    Arvidsson LE, Johansson AM, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Magnusson T, Carlsson A, Andersson B, Wikström H.
    J Med Chem; 1987 Nov 26; 30(11):2105-9. PubMed ID: 2959776
    [Abstract] [Full Text] [Related]

  • 13. Centrally acting serotonergic agents. Synthesis and structure-activity relationships of C-1- or C-3-substituted derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Lin CH, Haadsma-Svensson SR, Lahti RA, McCall RB, Piercey MF, Schreur PJ, VonVoigtlander PF, Chidester CG.
    J Med Chem; 1993 Mar 19; 36(6):671-82. PubMed ID: 8459396
    [Abstract] [Full Text] [Related]

  • 14. Thiophene analogs of naphthoxazines and 2-aminotetralins: bioisosteres with improved relative oral bioavailability, as compared to 5-OH-DPAT.
    Rodenhuis N, Timmerman W, Wikström HV, Dijkstra D.
    Eur J Pharmacol; 2000 Apr 14; 394(2-3):255-63. PubMed ID: 10771291
    [Abstract] [Full Text] [Related]

  • 15. Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: stereoselective interactions with 5-HT1A receptors in the brain.
    Björk L, Höök BB, Nelson DL, Andén NE, Hacksell U.
    J Med Chem; 1989 Apr 14; 32(4):779-83. PubMed ID: 2522991
    [Abstract] [Full Text] [Related]

  • 16. Derivatives of 2-(dipropylamino)tetralin: effect of the C8-substituent on the interaction with 5-HT1A receptors.
    Liu Y, Yu H, Svensson BE, Cortizo L, Lewander T, Hacksell U.
    J Med Chem; 1993 Dec 24; 36(26):4221-9. PubMed ID: 7506312
    [Abstract] [Full Text] [Related]

  • 17. Derivatives of cis-2-amino-8-hydroxy-1-methyltetralin: mixed 5-HT1A-receptor agonists and dopamine D2-receptor antagonists.
    Liu Y, Yu H, Mohell N, Nordvall G, Lewander T, Hacksell U.
    J Med Chem; 1995 Jan 06; 38(1):150-60. PubMed ID: 7530773
    [Abstract] [Full Text] [Related]

  • 18. Additive hypothermic effects of the 5-HT1A receptor agonist 8-OH-DPAT and the dopamine D2/3 receptor agonist 7-OH-DPAT in the rat.
    Eltayb A, Lindblom S, Oerther S, Ahlenius S.
    Acta Physiol Scand; 2001 Jul 06; 172(3):205-9. PubMed ID: 11472307
    [Abstract] [Full Text] [Related]

  • 19. (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: a putative 5-HT1A-receptor antagonist.
    Hillver SE, Björk L, Li YL, Svensson B, Ross S, Andén NE, Hacksell U.
    J Med Chem; 1990 Jun 06; 33(6):1541-4. PubMed ID: 2140413
    [No Abstract] [Full Text] [Related]

  • 20. 5-Hydroxy-2-methyl-2-(di-n-propylamino)tetralin: synthesis and central pharmacological effects.
    Hacksell U, Arvidsson LE, Johansson AM, Nilsson JL, Sanchez D, Andersson B, Lindberg P, Wikström H, Hjorth S, Svensson K.
    Acta Pharm Suec; 1985 Jun 06; 22(2):65-74. PubMed ID: 2996294
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.